Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech deals
Biotech
GSK strengthens COPD offering via $12B biobucks Hengrui deal
Having scored approval for Nucala in COPD, GSK has signed a major $12 billion deal to strengthen the pharma’s offering for the respiratory condition.
James Waldron
Jul 28, 2025 4:36am
Lilly links up with Gate in $856M biobucks deal
Jul 24, 2025 2:32pm
Matchpoint nets $60M in new Novartis deal
Jul 24, 2025 12:04pm
Otsuka inks $613M deal for Swedish biotech's IL1RAP antibodies
Jul 16, 2025 1:37pm
SandboxAQ, iOncologi partner to create brain cancer vaccine
Jul 16, 2025 10:58am
China biotechs ‘reshaping’ US biopharma: Jefferies report
Jul 14, 2025 2:30pm
